已收盘 09-20 16:00:00 美东时间
-0.030
-1.78%
Lexicon Pharmaceuticals (NASDAQ:LXRX) on Monday said its president and COO, Jeff Wade, is departing the company on or about September 30. The company said that a search for a new COO is underway. Wade...
09-16 20:41
Lexicon Pharmaceuticals ( ($LXRX) ) has shared an announcement. Jeffrey L. Wade...
09-16 19:18
Advisory Committee Meeting Scheduled for October 31, 2024; PDUFA Goal Date Remains December 20, 2024 Lexicon Seeks Approval for ZYNQUISTA™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control
08-21 20:06
Lexicon Pharmaceuticals Announces FDA Advisory Committee Meeting for Zynquista
08-21 20:00
Lexicon Pharmaceuticals Inc - Pdufa Goal Date Remains December 20, 2024
08-21 20:00
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Lexicon Pha...
08-14 00:06
北京时间2024年08月10日01时57分,莱斯康制药(LXRX.us)股票出现波动,股价快速下跌5.36%。截至发稿,该股报1.59美元/股,成交量105....
08-10 01:57
Lexicon Pharmaceuticals (NASDAQ:LXRX) said that efficacy and safety data for its drug sotagliflozin in the treatment of patients with type 1 diabetes and chronic kidney disease will be presented this ...
08-07 22:23
Throughout the last three months, 5 analysts have evaluated Lexicon Pharmaceuti...
08-03 02:09
Lexicon Pharmaceuticals Inc Files for Mixed Shelf of up to $200 Mln - SEC Filing
08-02 21:38